TP53 and metastatic melanoma: Altered ribosome biosynthesis may further TP53 stabilization and enrichment, affecting cellular proliferation and apoptosis and promoting tumor formation [80] The upregulation of DDX21 in this pathway further corroborates the risk for metastatic melanoma development in pseudo-albino individuals through melanocyte stem cell regeneration inhibition [81].